CCG Announces Excellence Award Winners at the 2006 ACS
News Jun 02, 2006
Chemical Computing Group (CCG) and the American Chemical Society's (ACS) Division of Computers in Chemistry (COMP) have congratulated the winners of the CCG Excellence Awards at the 232nd ACS National Meeting in San Francisco, California.
The well-regarded CCG Excellence Award honors graduate students who have excelled in the field of computational chemistry.
Winners are selected according to the distinction and relevance of their research, as well as the quality of supporting materials.
CCG will finance each awardee for travel costs to San Francisco for the Fall 2006 ACS; will recognize their research at the Awards Presentation during the COMP Division Poster Session on Tuesday September 12, 2006; and will give a one-year license for their software, the Molecular Operating Environment.
Fall 2006 ACS San Francisco, CA Winners:
Ying Wei, Northeastern University
High-recall, high-precision prediction of protein binding sites from 3D structure
Sara E. Nichols, Yale University
Shrinking residues for enhanced Monte Carlo sampling for proteins
Timothy H. Click, University of Oklahoma
Locating alpha-helices and beta-strands using recently-developed protocols
Johannes Hachmann, Cornell University
Quadratic Scaling Multireference Correlation in Polyenes and Long Molecules with the Local Density Matrix Renormalization Group
Zhi Wang, Emory University
Quantum Chemical Molecular Dynamics Study of Catalyst-Free SWNT Growth from SiC-derived Carbon
Tuberculosis (TB), an ancient and notoriously difficult disease to treat, has killed millions through the course of human history; and the antibiotics that have been used to fight the disease in recent history are becoming less and less effective. In the face of this reality, researcher Prof. Dennis Wright has improved upon a new way to thwart the tricky pathogen, mycobacterium tuberculosis.READ MORE
Researchers have solved the structures of the cancer-promoting enzymes USP25 and USP28, and identified significant differences in their activities. This knowledge provides the molecular basis for the development of new and highly specific anti-cancer drugs, with a low risk of side-effects.READ MORE